• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers diversify drug development options with new metal catalyst

Bioengineer by Bioengineer
January 9, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Photo by Fred Zwicky

CHAMPAIGN, Ill. — A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

Their findings appear in the journal Nature Chemistry.

Many pharmaceuticals contain aliphatic and aromatic carbon-hydrogen scaffolds to which chemists introduce oxygen atoms in precise locations to dictate the behavior of the drug. Aliphatic molecules have carbon-hydrogen bonds that are strong, ubiquitous and difficult to manipulate without affecting other, more reactive parts of the molecule. For example, aromatics have a type of bond that is often more reactive than aliphatic carbon-hydrogen bonds.

“Nature tells us in examples of drugs such as erythromycin and Taxol that by swapping out specific hydrogen atoms with oxygen atoms at strategic locations, chemists can control the function of a drug,” White said. “However, carbon-hydrogen bonds in aliphatic structures are some of the strongest in nature, and our previously developed methods to convert them to carbon-oxygen bonds – a process called oxidation – tend not to tolerate aromatics, which also are very prevalent in drugs.”

“We have developed a synthetic manganese catalyst that can oxidize aliphatic scaffolds in the presence of aromatics that serve as frameworks for most drugs,” White said. White often refers to what her group does as “molecular surgery.” Think of this manganese catalyst as analogous to a saw that can cut the skull without touching the brain, she said.

“Our new catalyst does the work of a complex enzyme, but is a simple substance that uses basic principles and can be stored in a refrigerator,” she said. “It will allow drug developers to replace a hydrogen atom with an oxygen atom without having to make a new drug from scratch.”

The team has used the new manganese catalyst to successfully demonstrate oxidation in 50 molecules, four of which are drug scaffolds, with the potential to rapidly produce derivatives having different biological activities or metabolites. This is important because metabolites – the byproducts of metabolizing a drug – sometimes cause side effects or are more active than the original drug, White said.

“Moving forward, we believe this catalyst may enable chemists to expedite the drug discovery process by producing new drugs from old ones and identifying metabolites without having to do new syntheses,” she said.

###

The National Institutes of Health, Uehara Memorial Foundation and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico supported this research.

Editor’s notes:
To reach M. Christina White, call 217-333-6173; mcwhite7@illinois.edu.
The paper “Chemoselective methylene oxidation in aromatic
molecules” is available online and from the U. of I. News Bureau.
DOI: 10.1038/s41557-018-0175-8.

Media Contact
Lois Yoksoulian
leyok@illinois.edu
217-244-2788

Original Source

https://news.illinois.edu/view/6367/737770

Related Journal Article

http://dx.doi.org/10.1038/s41557-018-0175-8

Tags: Chemistry/Physics/Materials SciencesPharmaceutical ChemistryPharmaceutical Sciences
Share12Tweet8Share2ShareShareShare2

Related Posts

Elastic Nanovesicle Gel Delivers Vardenafil to Relieve Peripheral Tissue Ischemia

Elastic Nanovesicle Gel Delivers Vardenafil to Relieve Peripheral Tissue Ischemia

November 20, 2026
Thai and Migrant Pregnancy Care Remained Resilient During the Pandemic

Thai and Migrant Pregnancy Care Remained Resilient During the Pandemic

November 20, 2026

Special Issue Evaluates Nanomaterial Targeting Strategies and Formulation Trade-Offs in Drug Delivery

November 20, 2026

Network Meta-Analysis Evaluates Eye Drops for Dry Eye After Cataract Surgery

November 20, 2026
Please login to join discussion

POPULAR NEWS

  • Biased Bubble Chain Navigation Helps Indoor Mobile Robots Accommodate Approaching Pedestrians

    Biased Bubble Chain Navigation Helps Indoor Mobile Robots Accommodate Approaching Pedestrians

    29 shares
    Share 12 Tweet 7
  • Thermophilic Fungus Engineered for High-Yield Bacterial Dipeptidyl Peptidase 4 Secretion

    29 shares
    Share 12 Tweet 7
  • Anterior Talar Osteotomy Corrects Equinus Deformity While Preserving Joint Congruence

    29 shares
    Share 12 Tweet 7
  • Biosensor Mouse Shows Mammary Defects Reversed by Estrogen and Genetic Crossing

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microelectronic Telemetry Chips Monitor Chemical Reactions Wirelessly Inside Test Tubes

Study Links METTL7B and SPP1 Signaling to Lung Squamous Cell Progression

Elastic Nanovesicle Gel Delivers Vardenafil to Relieve Peripheral Tissue Ischemia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.